| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $0 | +4.78K | +8.8% | $0.00 | 59.1K | Oct 12, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $0 | +2.45K | +4.15% | $0.00 | 61.6K | Oct 12, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Options Exercise | $0 | +549 | +0.89% | $0.00 | 62.1K | Oct 12, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Tax liability | -$557K | -1.88K | -3.03% | $296.04 | 60.2K | Oct 12, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Tax liability | -$286K | -965 | -1.6% | $296.04 | 59.3K | Oct 12, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Tax liability | -$63.9K | -216 | -0.36% | $296.04 | 59K | Oct 12, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$220K | -740 | -1.25% | $297.19 | 58.3K | Oct 13, 2021 | Direct | F1, F2 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$26.3K | -88 | -0.15% | $298.81 | 58.2K | Oct 13, 2021 | Direct | F3 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$168K | -558 | -0.96% | $300.35 | 57.7K | Oct 13, 2021 | Direct | F4 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$30.4K | -101 | -0.18% | $301.18 | 57.6K | Oct 13, 2021 | Direct | F5 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$44.6K | -150 | -0.26% | $297.21 | 57.4K | Oct 13, 2021 | Direct | F6 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$11.9K | -40 | -0.07% | $298.41 | 57.4K | Oct 13, 2021 | Direct | F7 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$16.2K | -54 | -0.09% | $299.78 | 57.3K | Oct 13, 2021 | Direct | F8 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$24K | -80 | -0.14% | $300.62 | 57.2K | Oct 13, 2021 | Direct | F9 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$2.71K | -9 | -0.02% | $301.30 | 57.2K | Oct 13, 2021 | Direct | |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$349K | -1.18K | -2.05% | $297.27 | 56.1K | Oct 13, 2021 | Direct | F10 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$119K | -400 | -0.71% | $298.43 | 55.7K | Oct 13, 2021 | Direct | F11 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$240K | -802 | -1.44% | $299.87 | 54.9K | Oct 13, 2021 | Direct | F12 |
| transaction | LII | Common Stock, Par Value $0.01 Per Share | Sale | -$158K | -524 | -0.96% | $300.88 | 54.3K | Oct 13, 2021 | Direct | F13 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -8.92K | -50% | $0.00 | 8.92K | Oct 12, 2021 | Common Stock, Par Value $0.01 Per Share | 8.92K | $214.63 | Direct | F14, F15 |
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -15.6K | -100% | $0.00* | 0 | Oct 12, 2021 | Common Stock, Par Value $0.01 Per Share | 15.6K | $205.53 | Direct | F14, F16 |
| transaction | LII | Non-qualified Stock Appreciation Right | Options Exercise | $0 | -4.17K | -20% | $0.00 | 16.7K | Oct 12, 2021 | Common Stock, Par Value $0.01 Per Share | 4.17K | $257.08 | Direct | F14, F17 |
| Id | Content |
|---|---|
| F1 | These sales (collectively) were effected pursuant to a Rule 10b5-1 trading plan. |
| F2 | Reflects a weighted average sale price of $297.194 at prices ranging from $296.76 to $297.59 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Reflects a weighted average sale price of $298.810 at prices ranging from 298.80 to $298.91 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Reflects a weighted average sale price of $300.349 at prices ranging from $299.92 to $300.91 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F5 | Reflects a weighted average sale price of $301.182 at prices ranging from $301.15 to $301.19 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F6 | Reflects a weighted average sale price of $297.208 at prices ranging from $296.85 to $297.51 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Reflects a weighted average sale price of $298.410 at prices ranging from $298.02 to $298.80 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F8 | Reflects a weighted average sale price of $299.783 at prices ranging from $299.20 to $300.17 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F9 | Reflects a weighted average sale price of $300.619 at prices ranging from $300.20 to $301.03 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F10 | Reflects a weighted average sale price of $297.273 at pricing ranging from $296.85 to $297.81 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F11 | Reflects a weighted average sale price of $298.432 at prices ranging from $298.03 to $298.85 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F12 | Reflects a weighted average sale price of $299.867 at prices ranging from $299.34 to $300.31 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F13 | Reflects a weighted average sale price of $300.88 at prices ranging from $300.50 to $301.18 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F14 | This exercise was affected pursuant to a Rule 10b5-1 trading plan. |
| F15 | One third of the Stock Appreciation Rights became exercisable on 12/7/2019 and each year thereafter. The entire grant will become fully exercisable on 12/7/2021. |
| F16 | One third of the Stock Appreciation Rights became exercisable on 12/8/2018 and each year thereafter. The entire grant became fully exercisable on 12/8/2020. |
| F17 | One third of the Stock Appreciation Rights became exercisable on 12/13/2020 and each year thereafter. The entire grant will become fully exercisable on 12/13/2022. |